Skip to main content

Advertisement

SpringerLink
Log in

Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study

  • Epidemiology of RMD
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Inception cohort study regarding the causes of death and risk factors for mortality in patients with early systemic sclerosis (SSc), especially diffuse SSc (dcSSc) has not been well elucidated. Therefore, the aim of our study was to determine the causes of death, survival rates, and risk factors for mortality in Thai patients with early SSc of whom the majority belonged to the dcSSc subset. We used an inception cohort of early-SSc patients seen between January 2010 and August 2014. All patients were evaluated for clinical and laboratory data at the study entry and then every 6 months. A total of 115 patients (68 female, 91 dcSSc) were enrolled. The mean ± SD age at onset, duration of disease, and duration of follow-up were 52.5 ± 8.5 years, 12.3 ± 9.2 months, and 27.5 ± 16.4 months, respectively. During the follow-up, 11(9.6%) SSc patients died. The mortality rate was 4.17 per 100 person-years (95% CI 2.31, 7.53). The leading cause of SSc-related death was dilated cardiomyopathy (27.2%). Infection was the most common cause of non-SSc-related death (18.2%). Survival rates at 1, 2, 3, and 4 years after the study entry were 93, 91, 88, and 88%, respectively. In the multivariate Cox regression analysis, ESR ≥ 40 mm/h [HR 8.65 (95% CI 1.66,45.17)], hemoglobin < 10 mg/dL [HR 4.57 (95% CI 1.14,18.34)], and mRSS [HR 1.09 (95% CI 1.03,1.15)] were independent risk factors for mortality. Our data suggest that dilated cardiomyopathy was the most common SSc-related cause of death in Thai patients with early SSc, of whom majority was dcSSc subset. Elevated ESR, anemia, and increased mRSS predicted poor outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 66:940–944

    Article  PubMed  PubMed Central  Google Scholar 

  2. Nihtyanova SI, Tang EC, Coghlan JG et al (2010) Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM 103:109–115

    Article  CAS  PubMed  Google Scholar 

  3. Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database. Ann Rheum Dis 69:1809–1815

    Article  PubMed  Google Scholar 

  4. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51:1017–1026

    Article  Google Scholar 

  5. Rubio-Rivas M, Royo C, Simeon CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208–219

    Article  PubMed  Google Scholar 

  6. Poormoghim H, Andalib E, Jalali A et al (2016) Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran. Rheumatol Int 36:925–934

    Article  PubMed  Google Scholar 

  7. Hashimoto A, Tejima S, Tono T et al (2011) Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 38:1931–1939

    Article  PubMed  Google Scholar 

  8. Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002) Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis. J Med Assoc Thail 85:1204–1209

    Google Scholar 

  9. Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG et al (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39:1971–1978

    Article  PubMed  Google Scholar 

  10. Simeon-Aznar CP, Fonollosa-Pla V, Tolosa-Vilella C et al (2015) Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore) 94:e1728

    Article  CAS  Google Scholar 

  11. Czirjak L, Kumanovics G, Varju C et al (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67:59–63

    Article  CAS  PubMed  Google Scholar 

  12. Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81:154–167

    Article  Google Scholar 

  13. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M (1994) Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheumatol 37:75–83

    Article  CAS  Google Scholar 

  14. Kim J, Park SK, Moon KW et al (2010) The prognostic factors of systemic sclerosis for survival among Koreans. Clin Rheumatol 29:297–302

    Article  PubMed  Google Scholar 

  15. Kuo CF, See LC, Yu KH et al (2011) Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 40:373–378

    Article  PubMed  Google Scholar 

  16. Santosa A, Tan CS, Teng GG et al (2016) Lung and gastrointestinal complications are leading causes of death in SCORE, a multi-ethnic Singapore systemic sclerosis cohort. Scand J Rheumatol. 45:1–8

    Article  Google Scholar 

  17. Louthrenoo W (2015) An insight into rheumatology in Thailand. Nat Rev Rheumatol 11:55–61

    Article  PubMed  Google Scholar 

  18. Masi AT et al (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  19. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576

    CAS  PubMed  Google Scholar 

  20. Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285

    CAS  PubMed  Google Scholar 

  21. Osiri M, Deesomchok U, Tugwell P (2001) Evaluation of functional ability of Thai patients with rheumatoid arthritis by the use of a Thai version of the Health Assessment Questionnaire. Rheumatology (Oxford) 40:555–558

    Article  CAS  Google Scholar 

  22. Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263

    Article  CAS  PubMed  Google Scholar 

  23. Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133

    Article  PubMed  Google Scholar 

  24. Avouac J, Walker U, Tyndall A et al (2010) Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR scleroderma trial and research group (EUSTAR) database. J Rheumatol 37:1488–1501

    Article  PubMed  Google Scholar 

  25. Hudson M, Baron M, Tatibouet S, Furst DE, Khanna D (2014) Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International scleroderma renal crisis survey. Semin Arthritis Rheum 43:666–672

    Article  CAS  PubMed  Google Scholar 

  26. van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755

    Article  PubMed  Google Scholar 

  27. Strickland G, Pauling J, Cavill C, Shaddick G, McHugh N (2013) Mortality in systemic sclerosis—a single centre study from the UK. Clin Rheumatol 32:1533–1539

    Article  PubMed  Google Scholar 

  28. Bryan C, Knight C, Black CM, Silman AJ (1999) Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 42:2660–2665

    Article  CAS  PubMed  Google Scholar 

  29. Hao Y, Hudson M, Baron M et al (2017) Early mortality in a multinational systemic sclerosis inception cohort. Arthritis Rheumatol (Hoboken, NJ) 69:1067–1077

    Article  Google Scholar 

  30. Meier FM, Frommer KW, Dinser R et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR scleroderma trials and research group database. Ann Rheum Dis 71:1355–1360

    Article  PubMed  Google Scholar 

  31. Fransen J, Popa-Diaconu D, Hesselstrand R et al (2011) Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis 70:1788–1792

    Article  CAS  PubMed  Google Scholar 

  32. Altman RD, Medsger TA Jr, Bloch DA, Michel BA (1991) Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403–413

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Mrs. Antika Wongthanee, medical statistician, for the statistical analysis.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand

    Suparaporn Wangkaew & Saowanee Puntana

  2. Division of Cardiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Narawudt Prasertwitayakij & Arintaya Phrommintikul

  3. Division of Diagnostic Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Juntima Euathrongchit

Authors
  1. Suparaporn Wangkaew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Narawudt Prasertwitayakij
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arintaya Phrommintikul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saowanee Puntana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juntima Euathrongchit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suparaporn Wangkaew.

Ethics declarations

Ethical standards

This study is conducted according to the principles expressed in the Helsinki Declaration of 1983 and it was approved by the Research Ethics Committee of Faculty of Medicine, Chiang Mai University, Thailand. All patients signed a written consent at study entry.

Conflict of interest

The authors have declared no conflict of interest.

Funding

This work was supported by Grants No. 27/2553 from the Chiang Mai University Endowment Fund, Faculty of Medicine, Chiang Mai University.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wangkaew, S., Prasertwitayakij, N., Phrommintikul, A. et al. Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int 37, 2087–2094 (2017). https://doi.org/10.1007/s00296-017-3846-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3846-7

Keywords

Search

Navigation